Package 63323-122-50

Brand: methotrexate

Generic: methotrexate sodium
NDC Package

Package Facts

Identity

Package NDC 63323-122-50
Digits Only 6332312250
Product NDC 63323-122
Product ID 63323-122_3d21237a-ef53-4592-bf06-0c739696203d
Description

1 VIAL in 1 CARTON (63323-122-50) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2000-01-22
Brand methotrexate
Generic methotrexate sodium
Sample Package No

Linked Drug Pages (1)

Methotrexate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRA-ARTERIAL", "INTRAMUSCULAR", "INTRATHECAL", "INTRAVENOUS"], "spl_id": "3d21237a-ef53-4592-bf06-0c739696203d", "openfda": {"unii": ["3IG1E710ZN"], "rxcui": ["311625"], "spl_set_id": ["ec476b11-0b3c-4139-b1eb-a3daa76bc271"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (63323-122-50)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "63323-122-50", "marketing_start_date": "20000122"}], "brand_name": "Methotrexate", "product_id": "63323-122_3d21237a-ef53-4592-bf06-0c739696203d", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "63323-122", "generic_name": "METHOTREXATE SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methotrexate", "active_ingredients": [{"name": "METHOTREXATE SODIUM", "strength": "1 g/1"}], "application_number": "ANDA040266", "marketing_category": "ANDA", "marketing_start_date": "20000122", "listing_expiration_date": "20261231"}